Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
EJNMMI Reports|September 8, 2024
[18F]AlF-PSMA-11 PET in diagnosing prostate cancer: a head-to-head comparison with [68Ga]Ga-PSMA-11 PET and an exploration of dual-phase scanningXiao Li, Mingming Yu, Jian Yang, et al.
EJNMMI Reports|September 1, 2024
3D dynamic diuretic renal scintigraphy using a hybrid whole body CZT SPECT/CT camera protocol in the evaluation of acute ureteric obstruction caused by ureteric stoneMiguel Ochoa-Figueroa, Klara Borbely, Diana Hasselqvist, et al.
EJNMMI Reports|July 7, 2024
Presentation of metastatic carotid body paraganglioma on F-18 FDG PET/CT: a rare diseaseMehul Dulet, Vaibhav Trivedi, Deepanksha Datta, et al.
EJNMMI Reports|June 13, 2024
3D-visualization of segmented contacts of directional deep brain stimulation electrodes via registration and fusion of CT and FDCTFadil Al-Jaberi, Matthias Moeskes, Martin Skalej, et al.
EJNMMI Reports|May 14, 2024
Clinical value of semi-quantitative parameters in 68Ga-DOTANOC PET/CT in treatment and diagnostics of cranial meningioma in a single-center retrospective analysisFriedrich Weitzer, Susanne Stanzel, Elisabeth Plhak, et al.
EJNMMI Reports|May 15, 2024
A systematic review of the challenges, emerging solutions and applications, and future directions of PET/MRI in Parkinson's diseaseIsabella Hoi Kei Leung, Mark William Strudwick
EJNMMI Reports|May 15, 2024
Efficacy and safety of FDG-PET for determining target volume during intensity-modulated radiotherapy for head and neck cancer involving the oral levelYasuo Kosugi, Keisuke Sasai, Naoya Murakami, et al.
EJNMMI Reports|May 15, 2024
Utility of metabolic ratios in the diagnosis of tumor Thrombus on F-18 FDG PET/CTDeepanksha Datta, Rajesh Kumar, Akhil Dhanesh Goel
EJNMMI Reports|May 15, 2024
Cardiac transplant rejection assessment with 18F-FDG PET-CT: initial single-centre experience for diagnosis and managementOwais Dar, Mansimran Singh Dulay, Fernando Riesgo-Gil, et al.
EJNMMI Reports|June 8, 2026
177Lutetium-PSMA-I&T therapy for metastatic castration-resistant prostate cancer (mCRPC): the first multicenter real-world study of 177Lu-PSMA-I&T in BrazilHelena F Bruzzi, Gabriela C K Lopes, Hannah B V Bekierman, et al.
Pageof 10